Abstract:Objective To evaluate the effectiveness and safety of the intravenous thrombolysis in acute stroke patients by recombinant tissue plasminogen activator (rtPA) within 4.5~9 hours under the guidance of multimode computed tomography (CT). Methods A total of 6 patients who were clinically diagnosed as acute ischemic stroke and reached hospital within 4.5~9 hours were recruited by Dept. of Neurology of Nanjing Drum Tower Hospital between 2008 and 2009. After the examination of multimode CT, the qualiifed patients were given intravenous thrombolysis treatment with rtPA (0.9mg/kg). The National Institute Health Stroke Scale (NIHSS) was assessed at baseline and 2h, 24h, 7d after the treatment. modiifed Rankin Scale (mRS) and the Barthel Index (BI) at 7d and 90d after the intravenous thrombolysis were calculated to evaluate neurological function and daily life capability respectively. Multimode CT was performed again at 24h after the treatment to calculate the recanalization of vessels. Thrombolysis in Cerebral Ischemia Scale (TICI) score was applied to assess the severity of vessel stenosis. Results Among 6 patients enrolled in the study, one patient developed cerebral hemorrhage. TICI grade score of 6 patients at 24 h after thrombolysis was signiifcantly increased compared with the baseline score (2.0+0.71vs 1.0+0.71,P=0.03). Except for the patients with cerebral hemorrhage, the NIHSS score of pre-treatment and 7 days post-treatment of the rest patients were 12.2±3.27 and 9.4±3.78 respectively, which achieved signiifcant statistic difference (P=0.04). In terms of the daily life capability, compared to 7 days after thrombolysis, BI score at 90 d was slightly improved and there was no signiifcant difference (62.5±27.23vs 47.5±27.84,P=0.13). The mRS scoce at 90 d was better than that at 7 d, but there was no signiifcant difference (4±0.82vs 3±0.82,P=0.09). Conclusion The intravenous thrombolysis treatment of acute ischemic stroke in the expanded time window under the guidance of multimode CT can promote the vessel recanalization, neural function recovery as well as daily activity restoration.

Extension of the Thrombolytic Time Window with Delayed Multiple Brain Protection in Rat Stroke Model

Neuroprotective effect of edaravone on focal cerebral ischemia in rats

Effect and safety of rt-PA combined with Hydroxyethyl starch in the treatment of acute cerebral infarction

Albumin combined with magnesium sulfate for prolonging thrombolytic time window in a rat stroke model

Combined Postischemic Hypothermia And Delayed Mk-801 Treatment Attenuates Neurobehavioral Deficits Associated With Transient Global-Ischemia In Rats

Effect of edaravone on the matrix metal-oproteinase-9 (MMP-9) expression after thrombolytic therapy for cerebral ischemia in rats

Clinical trial of combination therapy with ozagrel and vinpocetine in the treatment of stroke patients

Targeted Therapy of Ischemic Stroke Via Crossing the Blood-Brain Barrier Using Edaravone-Loaded Multiresponsive Microgels.

Effect of rt-PA and Edaravone on the Expression of MMP-9 in Rats with Cerebral Ischemic Injury

Combined intravenous recombinant tissue plasminogen activator and edaravone for ultra-acute ischemic stroke

Application of thrombolysis with rt-PA and edaravone in treatment of embolic stroke in the rat

Effects of Delayed Urokinase Thrombolysis on Microglia after Focal Cerebral Infarction in Rats

Case Analysis of Intravenous Thrombolysis in the Expanded Time Window under the Guidance of Multimode CT

Edaravone attenuates white matter lesions through endothelial protection in a rat chronic hypoperfusion model

Efficacy of Urinary Kallidinogenase Plus Intravenous Recombinant Tissue Plasminogen Activator for Stroke Patients With Extended Window: A Retrospective Analysis

Protective Effect of Edaravone on Free Radical Reaction after Cerebral Hemorrhage

Abstract 40: Xenon-Loaded Liposomes in Combination with IV Tpa Extends the Time Window for Treatment of Thrombotic Stroke

Multimode Computed-Tomography-Guided Thrombolysis under a Prolonged Time Window in Acute Ischemic Stroke Patients with Atrial Fibrillation.

The combination of deferoxamine and minocycline strengthens neuroprotective effect on acute intracerebral hemorrhage in rats

A Modified Thromboembolic Stroke Model of Rat Suitable for the Delayed Thrombolytic Therapy

Edaravone-Encapsulated Agonistic Micelles Rescue Ischemic Brain Tissue by Tuning Blood-Brain Barrier Permeability